Get the Stockscreener App
4.74
3.85%
-0.19
After Hours:
4.75
0.010
+0.21%
Coya Therapeutics Inc stock is traded at $4.74, with a volume of 65,297.
It is down -3.85% in the last 24 hours and down -0.21% over the past month.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
See More
Previous Close:
$4.93
Open:
$4.92
24h Volume:
65,297
Relative Volume:
0.29
Market Cap:
$99.18M
Revenue:
-
Net Income/Loss:
$-14.88M
P/E Ratio:
-4.8367
EPS:
-0.98
Net Cash Flow:
$-10.29M
1W Performance:
+7.24%
1M Performance:
-0.21%
6M Performance:
-22.68%
1Y Performance:
-28.29%
1-Day Range:
$4.69
$4.92
1-Week Range:
$4.43
$5.32
52-Week Range:
$3.9401
$8.29
Coya Therapeutics Inc Stock (COYA) Company Profile
Name
Coya Therapeutics Inc
Sector
Industry
Phone
650.739.3939
Address
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Compare COYA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
4.74 | 103.16M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Lake Street | Buy |
| Dec-04-24 | Initiated | D. Boral Capital | Buy |
Coya Therapeutics Inc Stock (COYA) Latest News
Published on: 2026-02-11 23:08:14 - baoquankhu1.vn
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial - BioSpace
Houston biotech co. raises $11M to advance ALS drug development - InnovationMap
New funding backs commercial readiness efforts for ALS therapy - ALS News Today
Price-Driven Insight from (COYA) for Rule-Based Strategy - Stock Traders Daily
HC Wainwright Predicts Higher Earnings for Coya Therapeutics - Defense World
HC Wainwright Analysts Raise Earnings Estimates for COYA - MarketBeat
Coya Therapeutics (NASDAQ:COYA) Receives “Buy” Rating from HC Wainwright - Defense World
Coya Therapeutics Announces $11.1 Million Private Placement - marketscreener.com
Coya Therapeutics (NASDAQ:COYA) Given "Buy" Rating at HC Wainwright - MarketBeat
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target - Investing.com Canada
Coya Therapeutics, Inc. (NASDAQ:COYA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Take Profit: Is Coya Therapeutics Inc impacted by rising ratesWeekly Risk Summary & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Outlook: Is Coya Therapeutics Inc impacted by rising ratesQuarterly Performance Summary & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Aug Drivers: Will ACXP outperform its industry peersMarket Movement Recap & High Return Trade Guides - baoquankhu1.vn
Market Fear: Does Coya Therapeutics Inc have strong fundamentals2025 Top Decliners & Low Risk Entry Point Guides - baoquankhu1.vn
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement - Yahoo Finance
Coya Therapeutics secures $11.1 million in private placement By Investing.com - Investing.com Australia
Coya Therapeutics secures $11.1 million in private placement - Investing.com India
Coya Therapeutics Sets $11.1 Million Private Placement Led by Dr. Reddy’s And Greenlight Capital - Pulse 2.0
Coya Therapeutics raises $11.1M in private placement led by Dr. Reddy's - MSN
Dr. Reddy's (RDY) Invests in Coya Therapeutics' Private Placemen - GuruFocus
Coya Therapeutics Announces Strategic Private Placement Financing - TipRanks
Coya Therapeutics Signs Securities Purchase Agreement With Dr. Reddy's Labs - TradingView
Coya Therapeutics, Inc. announced that it expects to receive $11.099999 million in funding - marketscreener.com
(COYA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Coya Therapeutics (COYA): Analyst Maintains 'Buy' Rating with St - GuruFocus
D. Boral Capital Reiterates Buy Rating for Coya Therapeutics (NASDAQ:COYA) - MarketBeat
Coya Therapeutics advances ALS and FTD clinical trials in 2026 By Investing.com - Investing.com South Africa
Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders - PharmiWeb.com
Coya Therapeutics Reports Strong Cash Position and Runway - TipRanks
Coya Therapeutics advances ALS and FTD clinical trials in 2026 - Investing.com
Will Coya Therapeutics Inc outperform its industry peers2025 Winners & Losers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Momentum Shift: Is PHAT currently under institutional pressureQuarterly Portfolio Review & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
COYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating - TipRanks
Coya Therapeutics, Inc. (NASDAQ:COYA) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Can Candel Therapeutics Inc. stock attract ESG capital inflows2025 Momentum Check & Consistent Return Strategy Ideas - Улправда
Is Coya Therapeutics Inc. stock a safe buy before earnings2025 AllTime Highs & Verified High Yield Trade Plans - Улправда
Is Coya Therapeutics Inc. stock a bargain at current levels2025 Year in Review & High Accuracy Swing Entry Alerts - Улправда
Is Coya Therapeutics Inc. stock a buy in volatile marketsJuly 2025 Trade Ideas & High Accuracy Investment Entry Signals - Улправда
Is Coya Therapeutics Inc. stock cheap compared to fundamentals2025 Key Lessons & Technical Pattern Based Buy Signals - Улправда
Support Test: How CERo Therapeutics Holdings Inc. stock benefits from global expansionTrade Analysis Report & Weekly Stock Performance Updates - ulpravda.ru
Chardan Capital Reiterates "Buy" Rating for Coya Therapeutics (NASDAQ:COYA) - MarketBeat
Aug Intraday: How Coya Therapeutics Inc. stock reacts to job market dataJuly 2025 Price Swings & Comprehensive Market Scan Reports - Улправда
Coya Therapeutics Inc Stock (COYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):